Genor BioPharma Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai China (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2011
NCT04175171
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Genor Biopharma Co., Ltd.